Brand / product

Zerbaxa

Ceftolozane + Tazobactam · 1 g + 0.5 g

ShareSend this page
₨ Official source-observed price PKR 16,946.85 1's
PKR 16,946.85 / vial/unit
✓ Official DRAP price source observed · Source checked 2026-11-13 · Price unchanged since 4 August 2025
Price Intelligence

Equivalent price position

Same generic · strength · dosage form · compatible unitPrice Intelligence PRO →
This brandPKR 16,946.85/ vial/unit
Price positionNo comparatorvs like-for-like peer median
Peer comparators0current-price listings
÷
Normalized unit pricePKR 16,946.85 / vial/unit

No other current listing with the same generic, strength, dosage form and compatible unit basis is available for comparison.

Price-position comparison uses current official listed prices normalized to compatible units. It is a price benchmark, not a measure of sales, demand, prescription volume or market share.

Product details

Generic
Ceftolozane + Tazobactam
Therapeutic area
Anti-infectives
Drug class
Third-generation cephalosporins
ATC
J01DI
Strength
1 g + 0.5 g
Dosage form
Powder for concentrate for solution for infusion
Pack
1's
Registration no.
115739
Price record verified
2026-08-08
Latest DRAP source check
2026-11-13 03:02

Manufacturer

Searle Pakistan Limited

Explore this manufacturer's complete MedInfoBase portfolio, generics and current listed prices.

View company portfolio →
Summary

About Zerbaxa 1 g + 0.5 g powder for concentrate for solution for infusion

Zerbaxa 1 g + 0.5 g powder for concentrate for solution for infusion contains Ceftolozane + Tazobactam 1 g + 0.5 g. It is registered with DRAP by Searle Pakistan Limited (registration no. 115739). Its official price is PKR 16,946.85 for a pack of 1's. The price changed from PKR 15,356.00 to PKR 16,946.85 on 4 August 2025. Zerbaxa is also available as 1 g + 0.5 g injection. No other brand of Ceftolozane + Tazobactam 1 g + 0.5 g in this form is listed in Pakistan.

Same brand

Other strengths of Zerbaxa

Alternatives (substitutes): same medicine, strength and form

Other brands of Ceftolozane + Tazobactam 1 g + 0.5 g infusion in Pakistan

No other brand of Ceftolozane + Tazobactam 1 g + 0.5 g infusion is listed in Pakistan. See all strengths and forms of Ceftolozane + Tazobactam →

How old is this price? It was fixed on 4 August 2025 and has not changed since — that is 15 months ago. It is still the price the Drug Regulatory Authority of Pakistan has notified, so it remains the official maximum, but it is not a figure from this month. Please check the current position before quoting it in an article, a tender or a purchase order.

Where to buy

MedInfoBase does not sell medicines and takes no orders. The company below holds the DRAP registration for Zerbaxa, so it is the right place for a pharmacy, distributor or hospital buyer to ask about supply. A patient should buy from a licensed pharmacy.

Registration holder
Searle Pakistan Limited, Karachi
DRAP registration
115739
Phone
+92 21 35822312-3; +92 21 35374436-7
Website
https://www.searlepakistan.com/
Contact page
Company contact page

Contact details as published by the company, last checked on 16 August 2026 (not yet independently verified). The price on this page is the official DRAP maximum retail price: a pharmacy may charge that or less, never more.

Price movement

Official price over time

PKR 15,356.00 to 16,946.85 (+10.4%) between 22 Aug 2023 and 4 Aug 2025 · 2 official price records · pack 1's

Step chart: a notified price holds until DRAP notifies the next one. Hover or tap a point for its date and change.

Cite this price history

MedInfoBase. Zerbaxa 1 g + 0.5 g, 1's: official price history (source: DRAP PharmaPrice Index). https://medinfobase.com/brand/zerbaxa-1-g-0-5-g-115739-1s-searle-pakistan-limited-1426/ (accessed 13 November 2026).

Traceability

Official price history

AmountEffective fromVerifiedSourceStatus
PKR 16,946.852025-08-042026-09-22DRAP PharmaPrice Index (recovered from snapshot #84)Current
PKR 15,356.002023-08-222026-09-24DRAP S.R.O. 1092(I)/2023 dated 22 Aug 2023 (MRP fixation)Historical
Evidence note: “Source observed” means MedInfoBase captured the record from an official DRAP source; it does not by itself mean the product registration was independently matched in the DRAP registry. Price note: Unit-price comparisons are informational calculations from official-source pack prices and normalized pack quantities. A pharmacy's transaction price may differ. Verify current regulatory and product information before professional use.

Cite this record

Medicine record · DRAP registration 115739
MedInfoBase. (2026). Zerbaxa 1 g + 0.5 g Powder for concentrate for solution for infusion (1's), Searle Pakistan Limited — registration and price record [Data set]. MedInfoBase. Retrieved November 13, 2026, from https://medinfobase.com/brand/zerbaxa-1-g-0-5-g-115739-1s-searle-pakistan-limited-1426/ Data observed 22 September 2026. Source: DRAP PharmaPrice Index (recovered from snapshot #84). DRAP registration 115739.
Download .RIS Download .BIB EndNote, Zotero, Mendeley, RefWorks

Price and registration data on this page were observed on 22 September 2026. Records change over time, so please cite the observation date alongside the access date.

Medicine brands A–Z:ABCDEFGHIJKLMNOPQRSTUVWXYZ0-9